Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ISRCTN12585158) titled 'Effects of a probiotic strain, Lacticaseibacillus rhamnosus OF44, on gut bacteria in healthy adults' on Oct. 11.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Treatment
Primary Sponsor: BGI Precision Nutrition (Shenzhen) Technology Co., Ltd. (China)
Condition:
Gut microbiota composition and faecal metabolite profile
Digestive System
Intervention:
Eligible participants are allocated in a 1:1:1 ratio to one of three arms using block randomisation:
Group 1 (probiotic): Lacticaseibacillus rhamnosus ...